You are here

Policy

 

Ethicists from the University of Basel have developed a biosecurity framework specific to neurotechnology while calling for a ban on dual-use technology with the aim of regulating mental privacy and integrity of humans. Findings were published in Neuron.

As cyberattack become increasingly common incidents, healthcare professionals must push security to the forefront. In a presentation given at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, Jim Whitfill, CMO of innovation Health Partners and president of Lumetis, described the current cybersecurity environment and detailed how professionals can take steps toward improving privacy.

Despite increased prevention efforts and longer lifespans, heart failure rates are at a high in the United Kingdom and are continuing to climb, according to new research published in The Lancet.

The U.S. Food and Drug Administration (FDA) has approved a remote feature allowing programming sessions given through telehealth platforms to patients who have had at least six months of experience with their cochlear implant sound processor.

The U.S. Food and Drug Administration (FDA) has approved the first digital pill with an ingestion tracking system to tell physicians whether patients have taken their medication.

 

Recent Headlines

FDA lists reusable medical devices requiring new validation

The U.S. Food and Drug Administration (FDA) has released a list of reusable medical devices that will require validated use instructions and data regarding cleaning, disinfection and sterilization.

ONC budget cut by $22 million under Trump

Under President Donald Trump's proposed budget, the Office of the National Coordinator for Health Information Technology (ONC) will lose $22 million in funding. The 36 percent reduction cuts the $60 million for ONC to $38 million in 2018.

CCHP report analyzes state telehealth laws, reimbursement policies

The Center for Connected Health Policy (CCHP) has released, "State Telehealth Laws and Reimbursement Policies," its fifth annual report analyzing all 50 states and the District of Columbia’s Medicaid provider manuals, state laws and telehealth regulations. 

Six legislators introduce bipartisan bill to expand telehealth

Six U.S. Senators have introduced the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017, a bipartisan bill that aims to extend telehealth services to Medicare patients to improve access and outcomes while reducing costs.

South Carolina hospitals check off 'reduce post-surgical deaths' with safety checklist

Having a checklist for chores or exercise goals help in lining up what needs to be completed and the same should go for safety in hospitals. A recent study, set to be published in August in the Annals of Surgery, found that having a safety checklist program implemented in hospitals in South Carolina reduced post-surgical deaths by 22 percent. 

FDA approves two hepatitis C drugs for pediatric patients

The U.S. Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) for the treatment of hepatitis C in pediatric patients, ages 12 to 17.

Former Siemens CMO Donald Rucker to lead ONC

According to a recent string of tweets, Donald Rucker, who served as CMO of Siemens Healthcare for 13 years, will head the U.S. Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology (ONC).

Trump HHS budget proposal raises FDA user fees

President Donald Trump's 2018 budget proposal for the U.S. Department of Health and Human Services (HHS) includes a doubling of U.S. Food and Drug Administration (FDA) user fees, putting added strain on small digital health businesses.

GOA to investigate FDA’s orphan drug program

The Government Accountability Office (GAO) has confirmed it will investigate the U.S. Food and Drug Administrations (FDA) Orphan Drug program following a letter from senators citing possible exploitation.

Device, drug makers would pay $1 billion extra to FDA under Trump budget

Included in President Donald Trump’s budget proposal for fiscal year 2018 is a big increase in what the medical device and pharmaceutical industries would pay the Food and Drug Administration (FDA) to cover the costs of reviewing their products.

Pages